These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33468668)

  • 1. Positive epistasis between disease-causing missense mutations and silent polymorphism with effect on mRNA translation velocity.
    Rauscher R; Bampi GB; Guevara-Ferrer M; Santos LA; Joshi D; Mark D; Strug LJ; Rommens JM; Ballmann M; Sorscher EJ; Oliver KE; Ignatova Z
    Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33468668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The silent codon change I507-ATC->ATT contributes to the severity of the ΔF508 CFTR channel dysfunction.
    Lazrak A; Fu L; Bali V; Bartoszewski R; Rab A; Havasi V; Keiles S; Kappes J; Kumar R; Lefkowitz E; Sorscher EJ; Matalon S; Collawn JF; Bebok Z
    FASEB J; 2013 Nov; 27(11):4630-45. PubMed ID: 23907436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Codon bias and the folding dynamics of the cystic fibrosis transmembrane conductance regulator.
    Bartoszewski R; Króliczewski J; Piotrowski A; Jasiecka AJ; Bartoszewska S; Vecchio-Pagan B; Fu L; Sobolewska A; Matalon S; Cutting GR; Rowe SM; Collawn JF
    Cell Mol Biol Lett; 2016; 21():23. PubMed ID: 28536625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization studies of rare missense mutations in cystic fibrosis transmembrane conductance regulator (CFTR) facilitate interpretation of genotype-phenotype relationships.
    Krasnov KV; Tzetis M; Cheng J; Guggino WB; Cutting GR
    Hum Mutat; 2008 Nov; 29(11):1364-72. PubMed ID: 18951463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1.
    Ren HY; Grove DE; De La Rosa O; Houck SA; Sopha P; Van Goor F; Hoffman BJ; Cyr DM
    Mol Biol Cell; 2013 Oct; 24(19):3016-24. PubMed ID: 23924900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of protein function by a silent polymorphism linked to tRNA abundance.
    Kirchner S; Cai Z; Rauscher R; Kastelic N; Anding M; Czech A; Kleizen B; Ostedgaard LS; Braakman I; Sheppard DN; Ignatova Z
    PLoS Biol; 2017 May; 15(5):e2000779. PubMed ID: 28510592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cystic fibrosis and congenital bilateral absence of the vas deferens-associated mutations on cystic fibrosis transmembrane conductance regulator-mediated regulation of separate channels.
    Mickle JE; Milewski MI; Macek M; Cutting GR
    Am J Hum Genet; 2000 May; 66(5):1485-95. PubMed ID: 10762539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes.
    Salvatore F; Scudiero O; Castaldo G
    Am J Med Genet; 2002 Jul; 111(1):88-95. PubMed ID: 12124743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relating the disease mutation spectrum to the evolution of the cystic fibrosis transmembrane conductance regulator (CFTR).
    Rishishwar L; Varghese N; Tyagi E; Harvey SC; Jordan IK; McCarty NA
    PLoS One; 2012; 7(8):e42336. PubMed ID: 22879944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations located in exon 24 of the CFTR gene are associated with a mild cystic fibrosis phenotype.
    Bienvenu T; Viel M; Leroy C; Van Esch H; Fajac I; Dusser D; Hubert D
    Clin Genet; 2003 Sep; 64(3):266-8. PubMed ID: 12919146
    [No Abstract]   [Full Text] [Related]  

  • 11. Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene mutations in North Egyptian population: implications for the genetic diagnosis in Egypt.
    El-Seedy A; Pasquet MC; Shafiek H; Morsi T; Kitzis A; Ladevèze V
    Cell Mol Biol (Noisy-le-grand); 2016 Nov; 62(13):21-28. PubMed ID: 28040058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mRNA-based detection of rare CFTR mutations improves genetic diagnosis of cystic fibrosis in populations with high genetic heterogeneity.
    Felício V; Ramalho AS; Igreja S; Amaral MD
    Clin Genet; 2017 Mar; 91(3):476-481. PubMed ID: 27174726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of premature termination codon mutations on CFTR mRNA abundance in human nasal epithelium and intestinal organoids: a basis for read-through therapies in cystic fibrosis.
    Clarke LA; Awatade NT; Felício VM; Silva IA; Calucho M; Pereira L; Azevedo P; Cavaco J; Barreto C; Bertuzzo C; Gartner S; Beekman J; Amaral MD
    Hum Mutat; 2019 Mar; 40(3):326-334. PubMed ID: 30488522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservation of CFTR codon frequency through primates suggests synonymous mutations could have a functional effect.
    Pizzo L; Iriarte A; Alvarez-Valin F; Marín M
    Mutat Res; 2015 May; 775():19-25. PubMed ID: 25839760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying Cystic Fibrosis Transmembrane Conductance Regulator Genetics and CFTR2 Data to Facilitate Diagnoses.
    Sosnay PR; Salinas DB; White TB; Ren CL; Farrell PM; Raraigh KS; Girodon E; Castellani C
    J Pediatr; 2017 Feb; 181S():S27-S32.e1. PubMed ID: 28129809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystic fibrosis transmembrane regulator haplotypes in households of patients with cystic fibrosis.
    Furgeri DT; Marson FAL; Correia CAA; Ribeiro JD; Bertuzzo CS
    Gene; 2018 Jan; 641():137-143. PubMed ID: 29054758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalized medicine in cystic fibrosis: genistein supplementation as a treatment option for patients with a rare S1045Y-CFTR mutation.
    Arora K; Yarlagadda S; Zhang W; Moon C; Bouquet E; Srinivasan S; Li C; Stokes DC; Naren AP
    Am J Physiol Lung Cell Mol Physiol; 2016 Aug; 311(2):L364-74. PubMed ID: 27261451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disrupted post-transcriptional regulation of the cystic fibrosis transmembrane conductance regulator (CFTR) by a 5'UTR mutation is associated with a CFTR-related disease.
    Lukowski SW; Bombieri C; Trezise AE
    Hum Mutat; 2011 Oct; 32(10):E2266-82. PubMed ID: 21837768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orphan missense mutations in the cystic fibrosis transmembrane conductance regulator: A three-step biological approach to establishing a correlation between genotype and phenotype.
    Fresquet F; Clement R; Norez C; Sterlin A; Melin P; Becq F; Kitzis A; Thoreau V; Bilan F
    J Mol Diagn; 2011 Sep; 13(5):520-7. PubMed ID: 21708286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotype-optimized sequence ensembles substantially improve prediction of disease-causing mutation in cystic fibrosis.
    Masica DL; Sosnay PR; Cutting GR; Karchin R
    Hum Mutat; 2012 Aug; 33(8):1267-74. PubMed ID: 22573477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.